Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin and Hypertonic Saline in Acute Heart Failure (DAPA-TONIC)
NCT06442280Phase 4Not yet recruiting
- Sponsor
- University of Palermo
- Start
- Jun 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dapagliflozin in acute heart failure (AHF), type 2 diabetes mellitus (T2DM), sponsored by University of Palermo. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
acute heart failure (AHF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06442280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06442280.